ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,189Medicare Part D Prescriptions Filled, Including Refills

Rank: 119 out of 324

$685K Total Retail Price of All Prescriptions

Rank: 47 out of 324

547 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
9% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

3% of this provider’s 547 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 7,762 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

32% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$84 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
ATORVASTATIN CALCIUM 435 411 1 12
SIMVASTATIN 381 356 2 1
LEVOTHYROXINE SODIUM 299 292 3 2
LISINOPRIL 254 244 4 3
METFORMIN HCL 239 218 5 9
AMLODIPINE BESYLATE 236 229 6 4
OMEPRAZOLE 207 198 7 6
LOSARTAN-HYDROCHLOROTHIAZIDE 200 198 8 44
LOSARTAN POTASSIUM 197 178 9 15
METOPROLOL SUCCINATE 175 167 10 17
ZOLPIDEM TARTRATE 172 171 11 20
CRESTOR 170 159 12 28
POTASSIUM CHLORIDE 154 152 13 8
TRAMADOL HCL-ACETAMINOPHEN 135 135 14 224
CITALOPRAM HBR 129 129 15 16
HYDROCHLOROTHIAZIDE 122 117 16 11
PRAVASTATIN SODIUM 114 111 17 21
SYNTHROID 112 105 18 30
ZETIA 105 98 19 68
WARFARIN SODIUM 103 103 20 10
GLYBURIDE 103 94 R 20 59
ALLOPURINOL 101 98 22 27
NEXIUM 93 92 23 33
METOPROLOL TARTRATE 89 85 24 14
ALENDRONATE SODIUM 85 85 25 24
BYSTOLIC 83 70 26 111
QUINAPRIL HCL 82 79 27 186
AZITHROMYCIN 81 75 28 48
FUROSEMIDE 81 81 28 7
RAMIPRIL 78 72 30 104
JANUVIA 72 68 31 83
PANTOPRAZOLE SODIUM 67 64 32 34
TRIAMTERENE-HCTZ 67 67 32 46
CARVEDILOL 66 62 34 22
TAMSULOSIN HCL 63 58 35 26
SPIRIVA 63 63 35 70
DIOVAN HCT 62 60 37 148
LIPITOR 59 59 38 109
FENOFIBRATE 57 57 39 79
PAROXETINE HCL 55 53 40 72
GABAPENTIN 52 43 41 13
RANITIDINE HCL 51 50 42 58
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 16, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.